XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 40,743,057 $ 4,361,758
Restricted cash 500,000
Accounts receivable-trade, less allowance for doubtful accounts of $123,751 and $123,224 – September 30, 2021 and December 31, 2020, respectively 2,356,411 1,705,461
Other receivables 1,621,053 1,529,920
Inventories, net 11,611,249 8,202,274
Prepaid expenses and other current assets 9,306,660 2,030,693
Total current assets 66,138,430 17,830,106
Property, plant and equipment, net 6,068,255 666,800
Goodwill and other intangible assets, net 16,454,946 392,564
Operating lease right of use assets, net 1,109,463 753,175
Other assets 2,121,158 1,154,882
Total assets 91,892,252 20,797,527
Current liabilities:    
Accounts payable 5,710,765 1,144,676
Accrued expenses 1,218,958 796,094
Current portion of operating lease obligations 384,222 113,484
Contract liabilities – current 1,630,529 1,647,469
Debt obligations – current 4,547,421 11,727
Warrant derivative liabilities 17,942,020
Income taxes payable 1,827 7,158
Total current liabilities 31,435,742 3,720,608
Long-term liabilities:    
Debt obligations – long term 846,979 148,273
Operating lease obligation, long term 795,704 723,272
Contract liabilities-long term 2,575,786 1,848,869
Total liabilities 35,654,211 6,441,022
Stockholders’ Equity:    
Common stock, $0.001 par value per share; 100,000,000 shares authorized; shares issued: 52,702,947 – September 30, 2021 and 26,834,709 – December 31, 2020 52,703 26,835
Additional paid in capital 123,968,757 106,501,396
Treasury stock, at cost (63,518 shares) (2,157,226) (2,157,226)
Noncontrolling interest in consolidated subsidiary (19,863)
Accumulated deficit (65,606,330) (90,014,500)
Total stockholders’ equity 56,238,041 14,356,505
Total liabilities and stockholders’ equity $ 91,892,252 $ 20,797,527